HUE063599T2 - Eljárások ödémás fibroszklerotikus pannikulopátia kezelésére vagy csökkentésére - Google Patents

Eljárások ödémás fibroszklerotikus pannikulopátia kezelésére vagy csökkentésére

Info

Publication number: HUE063599T2
Authority: HU; Hungary
Prior art keywords: edematous; reduction; treatment; methods; fibrosclerotic panniculopathy
Prior art date: 2011-10-21

Application number

HUE19172643A

Other languages

English (en)

Inventor

Susan Hart

Original Assignee

Endo Global Ventures

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-10-21

Filing date

2012-10-19

Publication date

2024-01-28

2012-10-19 Application filed by Endo Global Ventures filed Critical Endo Global Ventures

2024-01-28 Publication of HUE063599T2 publication Critical patent/HUE063599T2/hu

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24003—Microbial collagenase (3.4.24.3)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Physical Education & Sports Medicine (AREA)
Biomedical Technology (AREA)
Birds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Enzymes And Modification Thereof (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

HUE19172643A 2011-10-21 2012-10-19 Eljárások ödémás fibroszklerotikus pannikulopátia kezelésére vagy csökkentésére HUE063599T2 (hu)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201161549863P	2011-10-21	2011-10-21

Publications (1)

Publication Number	Publication Date
HUE063599T2 true HUE063599T2 (hu)	2024-01-28

Family

ID=48141393

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
HUE12842537 HUE044650T2 (hu)	2011-10-21	2012-10-19	Eljárás EFP kezelésére vagy csökkentésére
HUE19172643A HUE063599T2 (hu)	2011-10-21	2012-10-19	Eljárások ödémás fibroszklerotikus pannikulopátia kezelésére vagy csökkentésére

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
HUE12842537 HUE044650T2 (hu)	2011-10-21	2012-10-19	Eljárás EFP kezelésére vagy csökkentésére

Country Status (15)

Country	Link
US (1)	US20140335072A1 (hu)
EP (2)	EP2768523B1 (hu)
JP (4)	JP2014530873A (hu)
AU (5)	AU2012325941A1 (hu)
BR (1)	BR112014009785B1 (hu)
CA (1)	CA2852942C (hu)
DK (2)	DK2768523T3 (hu)
ES (2)	ES2741476T3 (hu)
FI (1)	FI3581199T3 (hu)
HK (1)	HK1201439A1 (hu)
HU (2)	HUE044650T2 (hu)
MX (2)	MX2014004792A (hu)
PL (1)	PL3581199T3 (hu)
PT (2)	PT3581199T (hu)
WO (1)	WO2013059619A1 (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK2802652T3 (da)	2012-01-12	2019-07-15	Endo Global Ventures	Clostridium histolyticum enzym
CA2872227A1 (en)	2012-05-01	2013-11-07	Proteolease Ltd.	Methods for extracting a tooth
AU2014228477B2 (en)	2013-03-15	2019-05-23	Biospecifics Technologies Corporation	Treatment method and product for uterine fibroids using purified collagenase
CN103751102A (zh) *	2014-01-15	2014-04-30	上海交通大学	一种胶原酶温敏水凝胶及其制备方法和应用
AU2018226820B2 (en) *	2017-03-01	2022-12-08	Endo Ventures Limited	Apparatus and method for assessing and treating cellulite
EP3601556A2 (en) *	2017-03-28	2020-02-05	Endo Ventures Limited	Improved method of producing collagenase
WO2020021332A2 (en) *	2018-07-12	2020-01-30	Endo Global Aesthetics Limited	Injection techniques for the treatment of cellulite
WO2020021330A2 (en) *	2018-07-12	2020-01-30	Endo Global Aesthetics Limited	Injection techniques for the treatment of cellulite
WO2020023406A1 (en) *	2018-07-23	2020-01-30	Nc8, Inc.	Cellulite treatment system and methods
KR20210079291A (ko) *	2018-09-18	2021-06-29	엔도 글로벌 에스테틱스 리미티드	셀룰라이트를 치료하기 위한 조성물 및 방법
CN113382714A (zh) *	2019-01-06	2021-09-10	恩多全球美学有限公司	胶原酶制剂及其制备方法
WO2021076618A1 (en)	2019-10-15	2021-04-22	The Johns Hopkins University	Treatment of uterine fibroids using purified collagenase
EP3861948A1 (en) *	2020-02-10	2021-08-11	Daniel A. Del Vecchio	Cellulite eradication methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4524065A (en) *	1983-08-04	1985-06-18	Bio-Specifics N.V.	Method for the prevention and treatment of scars with enzymes
US4645668A (en)	1983-08-04	1987-02-24	Biospecifics, Nv	Method for the prevention and treatment of scars with enzymes
US6958150B2 (en) *	1994-12-15	2005-10-25	Advance Biofactures Of Curacao, N.V.	Reduction of adipose tissue
PL2422789T3 (pl) *	2004-05-19	2018-09-28	Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center	Wstrzykiwalna kompozycja zawierająca deoksycholan sodu
US20070224184A1 (en) *	2006-02-22	2007-09-27	The Research Foundation Of The State University Of New York	Method for treating cellulite
US7811560B2 (en) *	2006-01-30	2010-10-12	Auxilium Us Holdings, Llc	Compositions and methods for treating collagen-mediated diseases
US8617543B2 (en) *	2007-02-14	2013-12-31	Yolare Pharmaceuticals, LLC	Modified mutant collagenase and its use in fat melting and in scar reduction

2012
- 2012-10-19 PT PT191726439T patent/PT3581199T/pt unknown
- 2012-10-19 DK DK12842537.8T patent/DK2768523T3/da active
- 2012-10-19 CA CA2852942A patent/CA2852942C/en active Active
- 2012-10-19 DK DK19172643.9T patent/DK3581199T3/da active
- 2012-10-19 WO PCT/US2012/061063 patent/WO2013059619A1/en active Application Filing
- 2012-10-19 EP EP12842537.8A patent/EP2768523B1/en active Active
- 2012-10-19 MX MX2014004792A patent/MX2014004792A/es active IP Right Grant
- 2012-10-19 JP JP2014537297A patent/JP2014530873A/ja active Pending
- 2012-10-19 HU HUE12842537 patent/HUE044650T2/hu unknown
- 2012-10-19 EP EP19172643.9A patent/EP3581199B1/en active Active
- 2012-10-19 ES ES12842537T patent/ES2741476T3/es active Active
- 2012-10-19 PL PL19172643.9T patent/PL3581199T3/pl unknown
- 2012-10-19 BR BR112014009785-2A patent/BR112014009785B1/pt active IP Right Grant
- 2012-10-19 AU AU2012325941A patent/AU2012325941A1/en not_active Abandoned
- 2012-10-19 FI FIEP19172643.9T patent/FI3581199T3/fi active
- 2012-10-19 PT PT12842537T patent/PT2768523T/pt unknown
- 2012-10-19 HU HUE19172643A patent/HUE063599T2/hu unknown
- 2012-10-19 ES ES19172643T patent/ES2953560T3/es active Active
2014
- 2014-04-17 US US14/255,407 patent/US20140335072A1/en not_active Abandoned
- 2014-04-21 MX MX2019007779A patent/MX2019007779A/es unknown
2015
- 2015-02-23 HK HK15101853.7A patent/HK1201439A1/xx unknown
2016
- 2016-03-31 AU AU2016202026A patent/AU2016202026A1/en not_active Abandoned
2017
- 2017-09-22 JP JP2017183076A patent/JP2018027968A/ja active Pending
- 2017-10-17 AU AU2017248451A patent/AU2017248451B2/en active Active
2020
- 2020-02-03 AU AU2020200763A patent/AU2020200763B2/en active Active
- 2020-06-16 JP JP2020103455A patent/JP2020158521A/ja active Pending
2022
- 2022-05-04 AU AU2022202987A patent/AU2022202987A1/en active Pending
- 2022-06-20 JP JP2022098817A patent/JP2022123073A/ja active Pending

Also Published As

Publication number	Publication date
ES2953560T3 (es)	2023-11-14
WO2013059619A1 (en)	2013-04-25
JP2022123073A (ja)	2022-08-23
AU2017248451A1 (en)	2017-11-02
PT2768523T (pt)	2019-08-29
US20140335072A1 (en)	2014-11-13
BR112014009785B1 (pt)	2020-06-30
AU2022202987A1 (en)	2022-05-26
JP2020158521A (ja)	2020-10-01
EP2768523A4 (en)	2015-04-22
NZ624057A (en)	2016-08-26
NZ769098A (en)	2022-03-25
HK1201439A1 (en)	2015-09-04
ES2741476T3 (es)	2020-02-11
JP2018027968A (ja)	2018-02-22
EP3581199A1 (en)	2019-12-18
NZ759819A (en)	2020-11-27
CA2852942A1 (en)	2013-04-25
DK3581199T3 (da)	2023-09-04
DK2768523T3 (da)	2019-07-22
PT3581199T (pt)	2023-08-31
EP3581199B1 (en)	2023-05-31
CA2852942C (en)	2023-01-10
NZ737403A (en)	2020-05-29
AU2012325941A1 (en)	2014-05-15
PL3581199T3 (pl)	2023-09-11
FI3581199T3 (fi)	2023-08-18
AU2020200763B2 (en)	2022-05-26
BR112014009785A2 (pt)	2017-04-25
AU2017248451B2 (en)	2019-11-14
NZ722722A (en)	2019-05-31
EP2768523A1 (en)	2014-08-27
AU2016202026A1 (en)	2016-04-21
BR112014009785A8 (pt)	2020-02-27
MX2019007779A (es)	2019-09-04
EP2768523B1 (en)	2019-05-22
JP2014530873A (ja)	2014-11-20
AU2020200763A1 (en)	2020-02-20
MX2014004792A (es)	2015-08-14
HUE044650T2 (hu)	2019-11-28

Publication	Publication Date	Title
EP2723384A4 (en)	2015-08-12	TREATMENT OF PROTEINOPATHIES
EP2773754A4 (en)	2015-06-10	Methods of Treatment
GB201110095D0 (en)	2011-07-27	Method of treatment
EP2717855A4 (en)	2014-11-12	PROCESSING METHODS
EP2670434A4 (en)	2015-11-11	TREATMENT OF TAUOPATHIA
IL226401A0 (en)	2013-07-31	Methods for treating disorders related to @fgfBA
ZA201304280B (en)	2014-08-27	Treatment of jak2-mediated conditions
HK1202253A1 (en)	2015-09-25	Combination treatment of cancer
HUE063599T2 (hu)	2024-01-28	Eljárások ödémás fibroszklerotikus pannikulopátia kezelésére vagy csökkentésére
GB201018147D0 (en)	2010-12-08	Method of treatment
IL230433A0 (en)	2014-03-31	Pain management methods
IL256026A (en)	2018-01-31	Treatment methods
IL228430A0 (en)	2013-12-31	Cancer treatment
GB201003920D0 (en)	2010-04-21	Method of treatment
EP2585103A4 (en)	2013-09-25	METHOD OF TREATMENT
GB201018149D0 (en)	2010-12-08	Method of treatment
EP2791324A4 (en)	2015-04-29	PROCESSING METHOD
GB201020015D0 (en)	2011-01-12	Method of treatment
GB201110602D0 (en)	2011-08-03	Methods of treatment
GB201109737D0 (en)	2011-07-27	Methods of treatment
GB201111530D0 (en)	2011-08-17	Method of treatment
GB201109509D0 (en)	2011-07-20	Method of treatment
GB201109266D0 (en)	2011-07-20	Method of treatment
GB201103044D0 (en)	2011-04-06	Method of treatment
GB201221118D0 (en)	2013-01-09	Methods of treatment